Evaluation of Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM
Background. Diabetic retinopathy (DR) is the leading cause of blindness in the world. Retinopathy can still progress despite optimal metabolic control. The aim of the study was to determine whether different degrees of DR (proliferative or nonproliferative) were associated with abnormally modulated...
Saved in:
| Main Authors: | Sefika Burcak Polat, Nagihan Ugurlu, Fatma Yulek, Huseyin Simavli, Reyhan Ersoy, Bekir Cakir, Ozcan Erel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2014/317292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Streptolysin O accelerates the conversion of plasminogen to plasmin
by: Di Tang, et al.
Published: (2024-11-01) -
Plasminogen and Plasmin as Key-Substances within the Fibrinolytic System
by: Egon E. Rickli
Published: (1978-01-01) -
Plasminogen influence on the PAI-1 release by human platelets
by: O. I. Yusova, et al.
Published: (2024-06-01) -
GENE POLYMORPHISMS OF ENDOTHELIAL DYSFUNCTION, COACTIVATORS OF MITOCHONDRIAL BIOGENESIS AND PLASMINOGEN/PLASMIN SYSTEM IN THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS
by: A. V. Shevchenko, et al.
Published: (2018-03-01) -
Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01)